LJPC — LA JOLLA PHARMACEUTICAL CO

Ownership history in PEAK6 Group LLC  ·  5 quarters on record

This page tracks every 13F SEC filing in which PEAK6 Group LLC reported a position in LA JOLLA PHARMACEUTICAL CO (LJPC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2017 Q3)
Avg. % of fund
0.0%
First filed
2017 Q3
Last filed
2018 Q1
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2018 Q1 REDUCED 5,800 -9,200 -61.3% 0.00% $173K —
2018 Q1 ADDED 15,000 +11,733 +359.1% 0.00% $447K —
2017 Q3 REDUCED 3,267 -12,733 -79.6% 0.00% $114K —
2017 Q3 REDUCED 16,000 -34,300 -68.2% 0.00% $556K —
2017 Q3 INITIATED 50,300 — — 0.01% $1.7M —
% of Fund (quarterly)

Other funds also holding LJPC

As of 2022 Q2 — sorted by position size

TANG KEVIN 3Y 99.74% Atle Fund Management AB 3Y 7Y 9.3% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 4.65% RTW INVESTMENTS, LP 3Y 7Y 0.19% GLOBEFLEX CAPITAL L P 3Y 7Y 0.05% HOLLENCREST CAPITAL MANAGEMENT 3Y 7Y 0.03% Running Point Capital Advisors, LLC 3Y 0.02% ACADIAN ASSET MANAGEMENT LLC 3Y 7Y 0.01% RITHOLTZ WEALTH MANAGEMENT 3Y 7Y 0.0% O'SHAUGHNESSY ASSET MANAGEMENT, LLC 3Y 7Y 0.0%
← Back to PEAK6 Group LLC Holdings